This site is intended for Healthcare professionals only.
×

Sanofi gets US FDA approval for new paediatric vaccine


Sanofi gets US FDA approval for new paediatric vaccine

Sanofi developed the new paediatric vaccine, dubbed Vaxelis, in partnership with Merck.

PARIS: The U.S. Food and Drug Administration approved Sanofi’s new paediatric vaccine immunizing children against six diseases, the French pharmaceutical lab said on Wednesday.

Sanofi developed the new vaccine, dubbed Vaxelis, in partnership with Merck.

Vaxelis is designed for children aged 6 weeks to 4 years old and is designed to keep them from contracting diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenza type B.

Sanofi and Merck are now working on the production and supply of Vaxelis aiming to make it available on the market in 2020 or later.

Read Also: Sanofi and Regeneron’s Dupixent gets more positive feedback from U.S.FDA

The following two tabs change content below.
MD Team

MD Team

At Medical Dialogues, we are a team of young professionals strongly advocating of the transparency in the medical sector through the free flow of medical information, health and medical news. MD Team covers a variety of news related to the healthcare, pharma and medical device industry in India. Our team can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751


Source: Reuters
0 comment(s) on Sanofi gets US FDA approval for new paediatric vaccine

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted